(2-(1-(1-((2R,3R)-3-(4-(4-(TERT-BUTYLCARBAMOYL)PHENYL)-1,3-THIAZOL-2-YL)-2-(2,5-DIFLUOROPHENYL)-2-HYDROXYBUTYL)-1,2,4-TRIAZOL-4-IUM-4-YL)ETHOXYCARBONYL-METHYLAMINO)-3-PYRIDINYL)METHYL 2-(METHYLAMINO)ACETATE
UNII V45AL459S9
Substance Identification & Data
This profile provides standardized clinical and technical data for (2-(1-(1-((2r,3r)-3-(4-(4-(tert-butylcarbamoyl)phenyl)-1,3-thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-1,2,4-triazol-4-ium-4-yl)ethoxycarbonyl-methylamino)-3-pyridinyl)methyl 2-(methylamino)acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V45AL459S9.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C39H45F2N8O6S GISOYMDZJAEYPX-ZOCFDYMLSA-O Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2-(1-(1-((2r,3r)-3-(4-(4-(tert-butylcarbamoyl)phenyl)-1,3-thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-1,2,4-triazol-4-ium-4-yl)ethoxycarbonyl-methylamino)-3-pyridinyl)methyl 2-(methylamino)acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.